NovoCure (NASDAQ:NVCR) just reported results for the first quarter of 2024.
- NovoCure reported earnings per share of -36 cents. This was above the analyst estimate for EPS of -42 cents.
- The company reported revenue of $138.50 million.
- This was 5.37% better than the analyst estimate for revenue of $131.45 million.